NDC 50090-2153-00 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-2153
- Requested NDC
- 50090-2153-00
- Package NDCs from labels
- 50090-2153-0, 50090-2153-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - A-S Medication Solutions | A-S Medication Solutions | 2024-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-2153-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | 43 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-2153 | DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS] | 43 | Current NDC, Legacy NDC, 1 package rows | 20241025_4034fb6d-f55d-4df0-b500-d6a413591f6e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-2153-0 | EA - Each | 50090-2153 | 421ab72c-a8c9-411c-bd3b-767009381793 | 1 | 2019-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 7aeaa0e1-136c-444d-b66c-7a5a96fb3022 | 2025-12-05 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 445dc831-1960-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Upsher-Smith laboratories, LLC | b5d1c604-ce3b-4973-845f-9db267a945cd | 2025-11-12 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | d42d2691-f25d-4dfc-99d0-3286d71480a4 | 2025-10-13 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 57f4a953-ad23-4a44-9956-c48aa5927132 | 2025-10-02 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | American Health Packaging | 3f4dc1a7-05e6-41d7-908c-30ce2677d87b | 2025-09-17 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | b4c974ad-cbd6-4811-ab48-461e7ffa99f7 | 2025-09-17 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 3ab222b7-74cc-5343-e063-6294a90a9616 | 2025-07-24 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 30b709d6-c438-c721-e063-6294a90abd61 | 2025-03-19 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 2e5cd8cb-7d43-e7af-e063-6294a90a310e | 2025-02-17 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| DOXAZOSIN | DOXAZOSIN | direct rx | b57cf33b-e0bd-54e9-e053-2a95a90a5a6a | 2025-01-17 | Warnings, Adverse reactions | ANDA202824 197626 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 88efdfb0-710f-768a-e053-2995a90aede4 | 2024-12-17 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Zydus Lifesciences Limited | ac889877-133c-4448-af5a-d77b3cbfe878 | 2024-11-28 | 197625 197628 197626 197627 86P6PQK0MU | |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 9b6170e7-814a-46ef-b068-cf3e6508d5e1 | 2024-10-21 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN MESYLATE | Aurobindo Pharma Limited | 93f2d724-5a54-4721-b04a-e46bc764607b | 2024-09-06 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 8c0c0345-833b-4a3d-9081-da66b208d750 | 2024-09-05 | Warnings, Adverse reactions | ANDA202824 197625 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.